Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Celermajer, D.S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Celermajer, D.S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Understanding the pathophysiology of the arterial wall: which method should we choose?

D.S. Celermajer*

Department of Cardiology, Royal Prince Abed Hospital, Sydney, New South Wales, Australia

* Correspondence: David Celermajer, Department of Cardiology, Royal Prince Alfred Hospital, Missenden Road, Camperdown 2050, Sydney, New South Wales, Australia.

Abstract

Atherosclerosis, the pathological process that underlies myocardial infarction, stroke and other occlusive vascular diseases, is the major cause of death in the Western world. Techniques that accurately and reproducibly detect and measure the early changes that occur in atherosclerosis and/or that identify those who are at highest cardiovascular risk may aid in the development of prevention strategies and may facilitate a decrease in morbidity and mortality from atherosclerosis. Improved understanding of the pathophysiology of early atherosclerosis has allowed development of a number of potential methods for the assessment of early stages in atherosclerosis in humans. These include techniques for assessing early structural changes in the coronary arteries using electron beam computed tomography and magnetic resonance imaging. External vascular ultrasound has also been used to image other circulations as a surrogate marker for coronary atherosclerosis (e.g. measurement of carotid artery intima-media thickness). Early functional changes in atherosclerosis have also been described many years before the development of structural changes. A number of techniques have been developed to measure endothelial dysfunction (one of the earliest changes in atherosclerosis), including non-invasive measurement of endothelial function using external vascular ultrasound. A variety of serum markers have also been described, and may be useful markers of atherosclerosis.

Key Words: Atherosclerosis • cardiovascular risk • imaging • pre-symptomatic detection

References

  1. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9(suppl 1):19–32
  2. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–2478[Abstract/Free Full Text]
  3. Mizuno K, Arakawa K, Isojima K, et al. Angioscopy, coronary thrombi and acute coronary syndromes. Biomed Pharmacother. 1993;47:187–191[CrossRef][Medline]
  4. Bauters C, Lablanche JM, Renaud N, McFadden EP, Hamon M, Bertrand ME. Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J. 1996;17:1554–1559[Abstract/Free Full Text]
  5. Hohier M, Hombach V, Wohrle J. Angioscopic predictors of restenosis following coronary angioplasty: the impact of yellow smooth plaques. Z Kardiol. 2001;90:111–119[CrossRef][Web of Science][Medline]
  6. Kern MJ, Meier B. Evaluation of the culprit plaque and the physiological significance of coronary atherosclerotic narrowings. Circulation. 2001;103:3142–3149[Free Full Text]
  7. Brezinski M, Saunders K, Jesser C, Li X, Fujimoto J. Index matching to improve optical coherence tomography imaging through blood. Circulation. 2001;103:1999–2003[Abstract/Free Full Text]
  8. Brennan JF III, Romer TJ, Lees RS, Tercyak AM, Kramer JR Jr, Feld MS. Determination of human coronary artery composition by Raman spectroscopy. Circulation. 1997;96:99–105[Abstract/Free Full Text]
  9. Buschman HP, Marple ET, Wach ML, et al. In vivo determination of the molecular composition of artery wall by intravascular Raman spectroscopy. Ann Chem. 2000;72:3771–3775[CrossRef]
  10. Casscells W, Hathorn B, David M, et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996;347:1447–1451[CrossRef][Web of Science][Medline]
  11. Stefanadis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: a new method of detection by application of a special thermography catheter. Circulation. 1999;99:1965–1971[Abstract/Free Full Text]
  12. de Korte CL, van der Steen AF, Cepedes EI, et al. Characterization of plaque components and vulnerability with intravascular ultrasound elastography. Phys Med Biol. 2000;45:1465–1475[CrossRef][Web of Science][Medline]
  13. Ridker PM. Inflammation infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998;97:1671–1674[Free Full Text]
  14. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease eases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:4219–4225[Abstract/Free Full Text]
  15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809[CrossRef][Medline]
  16. Worthley SG, Osende JI, Helft G, Badimon JJ, Foster V. Coronary artery disease: pathogenesis and acute coronary syndromes. Mt Sinai J Med. 2001;68:167–181[Medline]
  17. Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998;32:368–372[Abstract/Free Full Text]
  18. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol. 1998;32:S62–S66
  19. Weber C, Erl W, Weber PC. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. Biochem Biophys Res Common. 1995;206:621–628[CrossRef][Web of Science][Medline]
  20. Ritchie ME. Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris. Circulation. 1998;98:1707–1713[Abstract/Free Full Text]
  21. Stefanadis C, Diamantopoulos L, Dernellis J, et al. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol. 2000;32:43–52[CrossRef][Web of Science][Medline]
  22. Albert MA, Ridker PM. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep. 1999;1:99–104[Medline]
  23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979[Abstract/Free Full Text]
  24. Nilsson J. Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis. 1986;62:185–199[CrossRef][Web of Science][Medline]
  25. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol. 1990;16:207–222[Abstract]
  26. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994;24:1591–1601[Abstract]
  27. Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension. 1989;13:658–667[Abstract/Free Full Text]
  28. Cooke JP, Tsao PS. Is NO an endogenous antiatherogenic molecule? Arterioscler Thromb. 1994;14:653–655[Free Full Text]
  29. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997–1001[Abstract]
  30. Haak T, Marz W, Jungmann E, et al. Elevated endothelin levels in patients with hyperlipoproteinemia. Clin Invest. 1994;72:580–584[Web of Science][Medline]
  31. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046–1051[Abstract]
  32. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899–1906[Abstract/Free Full Text]
  33. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterollowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993;341:1496–1500[CrossRef][Web of Science][Medline]
  34. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Celermajer, D.S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Celermajer, D.S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?